I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Ophthalmic Plastic and Reconstructive Surgery
The oculofacial plastic surgeons at the Johns Hopkins Wilmer Eye Institute specialize in cosmetic and reconstructive procedures designed to improve the appearance and function of the eyelids and face, allowing patients to look and feel natural again.
The eyelids and structures around the eyes are critical for vision. Injuries, congenital defects, aging changes and tumors can cause pain, eye damage, vision loss and disfigurement. Changes in the eye's appearance can decrease one's ability to interact in social settings and in the workplace. The tragic loss of an eye from injury or disease can decrease one's confidence and impair self-image.
Along with a variety of cosmetic procedures, our surgeons can insert implants, reconstruct eyelids and eye sockets, correct eyelid-position abnormalities, remove growths and rebuild critical ocular structures.
Find out more about our seven convenient office locations in Maryland.
Cosmetic ServicesLearn more about our procedures for the eyelids, brow, and face restore a more youthful appearance.
Learn more about how we restore form and function to the eye and face after disease, trauma or injury.
Meet the team of experts who apply the latest research and technologies to deliver the best ophthalmic plastic and reconstructive surgery services.
To schedule an appointment with Oculoplastic Surgery at the Wilmer Eye Institute, call us at 410-955-1112 or toll free at 1-800-21JOHNS (1-800-215-6467) and ask to be switched to the Wilmer Referral Office. If this is an emergency, you may visit the Wilmer Eye Emergency Service, which is open 24 hours a day, 7 days a week at The Johns Hopkins Hospital.
The Oculoplastic Surgery division accepts cash, checks and credit cards. While some treatments are classified as medical procedures and are covered by insurance, certain procedures may not be covered. Request an appointment to find out more.
News and Events
Study to Use Celecoxib (Celebrex®) as Treatment for Thyroid Eye Disease
Dr. Timothy McCulley will lead a study that uses celecoxib, a nonsteroidal, anti-inflammatory drug, as an alternative early treatment for thyroid eye disease. The study is funded by the Oliver and Harriet Sockwell Foundation, which focuses on health and education issues.
The Impact of Age-related Eyelid Changes
Request an Appointment
Already a Patient?
Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.